Novel Tx for Binge-Eating Cuts Weight in Obese Adults |
Clinical News
eMediNexus Coverage from: 
Novel Tx for Binge-Eating Cuts Weight in Obese Adults
eMediNexus,  08 October 2019
remove_red_eye 562 Views
#Diabetes and Endocrinology #Pharmacist #Public Health

1 Read Comments                

Dasotraline, a novel binge eating disorder treatment, helped reduce body weight in a secondary analysis, a researcher reported at Psych Congress 2019.

After 12 weeks, the once-daily investigational long-acting dopamine/norepinephrine reuptake inhibitor was associated with a significant 12.57 lb (5.7 kg) reduction in body weight compared with a 0.88 lb (0.4 kg) gain in placebo, according to Leslie Citrome, MD, of New York Medical College in Valhalla. Study participants on dasotraline also saw a 2-point reduction in BMI versus a 0.2 increase among those on placebo, she reported.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now